These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29443543)

  • 1. ABCB1 1199G > A Polymorphism Impacts Transport Ability of P-gp-Mediated Antipsychotics.
    Wang R; Sun X; Deng YS; Qiu XW
    DNA Cell Biol; 2018 Apr; 37(4):325-329. PubMed ID: 29443543
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Gao YL; He B
    DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
    Peng R; Zhang H; Zhang Y; Wei DY
    Xenobiotica; 2016 Oct; 46(10):948-52. PubMed ID: 26822676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines.
    Dessilly G; Elens L; Panin N; Capron A; Decottignies A; Demoulin JB; Haufroid V
    PLoS One; 2014; 9(3):e91555. PubMed ID: 24621983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): comparison of rat P-glycoprotein transport to human and mouse.
    Booth-Genthe CL; Louie SW; Carlini EJ; Li B; Leake BF; Eisenhandler R; Hochman JH; Mei Q; Kim RB; Rushmore TH; Yamazaki M
    J Pharmacol Toxicol Methods; 2006; 54(1):78-89. PubMed ID: 16545584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
    Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
    Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.
    Katoh M; Suzuyama N; Takeuchi T; Yoshitomi S; Asahi S; Yokoi T
    J Pharm Sci; 2006 Dec; 95(12):2673-83. PubMed ID: 16892207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the
    Peng R; Zhang H; Zhang Y; Wei DY
    Med Sci (Basel); 2015 Dec; 3(4):124-137. PubMed ID: 29083397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
    Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
    J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
    Shen XM; Cheng J
    DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
    Takeuchi T; Yoshitomi S; Higuchi T; Ikemoto K; Niwa S; Ebihara T; Katoh M; Yokoi T; Asahi S
    Pharm Res; 2006 Jul; 23(7):1460-72. PubMed ID: 16779700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
    Tan DQ
    Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
    Woodahl EL; Crouthamel MH; Bui T; Shen DD; Ho RJ
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):183-8. PubMed ID: 19123050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
    Wang JS; Zhu HJ; Markowitz JS; Donovan JL; DeVane CL
    Psychopharmacology (Berl); 2006 Sep; 187(4):415-23. PubMed ID: 16810505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier.
    Poller B; Wagenaar E; Tang SC; Schinkel AH
    Mol Pharm; 2011 Apr; 8(2):571-82. PubMed ID: 21309545
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jiang B; Yan LJ; Wu Q
    DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between P-glycoprotein and second-generation antipsychotics.
    Moons T; de Roo M; Claes S; Dom G
    Pharmacogenomics; 2011 Aug; 12(8):1193-211. PubMed ID: 21843066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
    Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; DeVane CL
    Neuropsychopharmacology; 2007 Apr; 32(4):757-64. PubMed ID: 16936711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions.
    Zolnerciks JK; Booth-Genthe CL; Gupta A; Harris J; Unadkat JD
    J Pharm Sci; 2011 Aug; 100(8):3055-3061. PubMed ID: 21484807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A; Gutmann H; Drewe J
    Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.